Novis E, Glover A, Grady JP, Silvestri A, et al. Oncogenic mutations in the TP53 and PI-3 kinase/AKT pathway are independent predictors of survival for advanced thyroid cancer: Analysis from the Molecular Screening and Therapeutics (MoST) program. Surgery 2024 Oct 17:S0039-6060(24)00781-5. doi: 10.1016/j.surg.2024.
PMID: 39424488